Shares of Amrize Ltd (NYSE:AMRZ – Get Free Report) have received an average rating of “Moderate Buy” from the seventeen research firms that are covering the firm, MarketBeat reports. Six analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $64.1429.
AMRZ has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Amrize in a report on Monday, February 23rd. Oppenheimer reissued an “outperform” rating and set a $70.00 target price (up from $64.00) on shares of Amrize in a report on Thursday, February 19th. UBS Group increased their target price on Amrize from $53.00 to $57.00 and gave the stock a “neutral” rating in a research report on Thursday, January 8th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $70.00 price target on shares of Amrize in a report on Thursday, December 18th. Finally, Royal Bank Of Canada lifted their price target on Amrize from $60.00 to $61.00 and gave the company a “sector perform” rating in a research report on Thursday, February 19th.
Read Our Latest Stock Report on Amrize
Insider Buying and Selling at Amrize
Institutional Trading of Amrize
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Geode Capital Management LLC purchased a new stake in Amrize in the 2nd quarter worth approximately $265,000. Russell Investments Group Ltd. purchased a new position in shares of Amrize during the 2nd quarter valued at $20,852,000. Choreo LLC purchased a new position in shares of Amrize during the 2nd quarter valued at $257,000. Korea Investment CORP bought a new position in shares of Amrize in the second quarter worth $14,105,000. Finally, Grantham Mayo Van Otterloo & Co. LLC bought a new position in shares of Amrize in the second quarter worth $1,331,000.
Amrize Price Performance
NYSE AMRZ opened at $53.79 on Tuesday. The company has a market cap of $29.75 billion and a PE ratio of 21.87. Amrize has a 52 week low of $44.12 and a 52 week high of $65.94. The company has a quick ratio of 1.10, a current ratio of 1.64 and a debt-to-equity ratio of 0.37. The firm’s 50-day simple moving average is $57.77 and its two-hundred day simple moving average is $53.82.
Amrize (NYSE:AMRZ – Get Free Report) last posted its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, topping the consensus estimate of $0.59 by $0.03. The business had revenue of $2.84 billion during the quarter, compared to analysts’ expectations of $2.95 billion. The company’s revenue for the quarter was down .4% compared to the same quarter last year.
Amrize Announces Dividend
The business also recently announced a dividend, which will be paid on Monday, May 4th. Shareholders of record on Monday, April 27th will be paid a $0.44 dividend. The ex-dividend date is Friday, April 24th.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Recommended Stories
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
